Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127083491 | 12708349 | 1 | I | 2015 | 20160815 | 20160901 | 20160901 | PER | US-ELI_LILLY_AND_COMPANY-US201608008153 | ELI LILLY AND CO | 67.79 | YR | F | Y | 0.00000 | 20160901 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127083491 | 12708349 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 30 MG, QD | 21427 | 30 | MG | CAPSULE | QD | ||||||
127083491 | 12708349 | 2 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 60 MG, QD | 21427 | 60 | MG | CAPSULE | QD | ||||||
127083491 | 12708349 | 3 | SS | DULOXETINE HYDROCHLORIDE. | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 30 MG, QD | 0 | 30 | MG | QD | |||||||
127083491 | 12708349 | 4 | SS | DULOXETINE HYDROCHLORIDE. | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 60 MG, QD | 0 | 60 | MG | QD | |||||||
127083491 | 12708349 | 5 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
127083491 | 12708349 | 6 | C | TOPAMAX | TOPIRAMATE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
127083491 | 12708349 | 7 | C | IRBESARTAN. | IRBESARTAN | 1 | Unknown | UNK, UNKNOWN | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127083491 | 12708349 | 1 | Fibromyalgia |
127083491 | 12708349 | 3 | Fibromyalgia |
127083491 | 12708349 | 5 | Thyroid disorder |
127083491 | 12708349 | 6 | Migraine |
127083491 | 12708349 | 7 | Hypertension |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127083491 | 12708349 | Asthenia | |
127083491 | 12708349 | Chills | |
127083491 | 12708349 | Confusional state | |
127083491 | 12708349 | Diarrhoea | |
127083491 | 12708349 | Dizziness | |
127083491 | 12708349 | Drug ineffective | |
127083491 | 12708349 | Dysuria | |
127083491 | 12708349 | Feeding disorder | |
127083491 | 12708349 | Nausea | |
127083491 | 12708349 | Pyrexia | |
127083491 | 12708349 | Tinnitus | |
127083491 | 12708349 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127083491 | 12708349 | 1 | 2014 | 0 | ||
127083491 | 12708349 | 2 | 2014 | 0 |